Skip to main content
Advertisement
Advertisement

ALNY

ALNY logo

Alnylam Pharmaceuticals, Inc.

231.83
USD
Sponsored
-2.20
-0.94%
Oct 16, 15:59 UTC -4
Closed
exchange

After-Market

231.93

+0.09
+0.04%

Alnylam Pharmaceuticals, Inc. Financial Snapshot

Market Cap
31.03B
Beta
0.28
Earnings Per Share (EPS)
5.38
Price-to-Book (P/B) Ratio
23.13
Operating Margin
15.26%
Total Debt/Equity (D/E)
74.66%
P/E Ratio
43.50
Return on Equity (ROE)
84.93%
Current Ratio
3.05%
Free Cash Flow
340.71M

Earnings Chart

Latest News & Forecasts

Advertisement